Member Info for ThinShins

My thoughts exactly Joey, just shows how expensive it is to conduct these trials and this is just one site.

Can someone clarify what is "Dollar amount: $233,167.52" is in reference to on the below link, UOA receivied this from Synairgen to conduct the trial?

https://healthsciences.arizona.edu/connect/grants/randomised-double-blind-placebo-controlled-phase-iii-trial-determine-efficacy-and

Many thanks

Ghia, most holders attention is on ACTIV-2 due to SPRINTER being delayed again and A2 being the most likely next update.

I agree with you that ACTIV-2 is not the be all and end all for Synairgen but it is a major trial we are part of and if we progress it will be the catalyst for a decent rise in SP. Do you really expect investors to not focus on and discuss a trial which is due an update anytime now?

Prion I think you make a great point with regards to A2 measuring viral loads, with SNG001 being inhaled into the lungs I am confident they will see considerable reduction in viral load and this alone will hopefully be enough for them to progress us into P3.

Do we have the viral load data available on the other treatments that have graduated to P3 so far?

I also think many people forget that A2 is not our only route in to the US, if we do not progress we will still have a route via Sprinter albeit a different patient setting.

Unfortunately they are hellbent on a tablet/capsule treatment. Investors in #VELA believe one of these new treatments will be a repurposed diabetes drug AZD1656

@Blessed22 “I am not expecting an RNS”

@BeContrarian “we know news could be a little way off just yet.”

Are you guys referring to SG018 p3? If so I agree, p3 results couple months away.

However don’t forget we are still waiting on an update for ACTIV-2 p2, which IMO is way overdue so we could have a RNS tomorrow. I hope so anyways.

Courtesy of @TheLuggage4 on Twitter.

Not sure how this would apply to SNG as no mention of the interferon being inhaled but very interesting and good reading although vast majority went over my head,

https://twitter.com/frontimmunol/status/1434812753051480075?s=21

https://inews.co.uk/news/covid-lockdown-government-plans-october-firebreak-restrictions-hospital-admissions-1185533

"So important are IFN-Is, that it is perhaps not surprising that many viruses have evolved mechanisms to block the triggering of IFN-I production and sometimes to additionally block IFN-I signaling."

gggg21, firstly thanks for your continued great research as always. In regards to what you are talking about I do remember Prof Wilkinson mention on one of. His presentations that there could be potential trial for ICU patients, could it be related to this? Just thinking out loudly

Can someone help me understand why as of yet we haven't seen this released in the form of a RNS? I thought that confirmation of phase 2 being filled would be considered market sensitive info?

Isn't p2 being filled worthy of a RNS?

Great to hear us mentioned by name for once and not just interferon.

sledgey121, hope a speedy recovery for you and your family.

Doc, if what you saying is accurate then I smell some foul play and maybe some favouritism unless there is a good reason why the candidates you mentioned have completed or nearly completed phase 2/3 while we are still sat here twiddling our thumbs wondering what is going on with activ2 p2. Why do you reckon it is taking so long for a decision to be made.?

Hi All,

Just curious to know what all your predictions are for the SP, if/when the RNS lands confirming Govt orders.

Personally my exit price is £2 so fingers crossed for that.

Best of luck to all genuine holders.

@Mikethai, its clear for all to see as to why he is here, to cause disruption, sow seeds of doubt, put a negative spin on every bit of news regarding odx.

10p according to Jwd222…

Allah4Uk - Chill out Uri Geller, I’ve not upvoted anything.

Twatcher, genuine question, do you own shares in ODX?